Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19981 | 481 | 35.8 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
375 | 3 | MELANOMA//DERMATOLOGY//DERMATOL | 32727 |
243 | 2 | MELANOMA//MALIGNANT MELANOMA//DERMOSCOPY | 19979 |
19981 | 1 | MIA//CIRCULATING MELANOMA CELLS//MELANOMA INHIBITORY ACTIVITY | 481 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MIA | authKW | 914098 | 7% | 40% | 36 |
2 | CIRCULATING MELANOMA CELLS | authKW | 512083 | 2% | 73% | 11 |
3 | MELANOMA INHIBITORY ACTIVITY | authKW | 466444 | 3% | 57% | 13 |
4 | CD RAP | authKW | 451426 | 2% | 89% | 8 |
5 | TYROSINASE MRNA | authKW | 428499 | 2% | 75% | 9 |
6 | MELANOMA INHIBITING ACTIVITY | authKW | 317410 | 1% | 100% | 5 |
7 | SERUM S100 PROTEIN | authKW | 317410 | 1% | 100% | 5 |
8 | MELANOMA INHIBITORY ACTIVITY MIA | authKW | 253928 | 1% | 100% | 4 |
9 | MIA MELANOMA INHIBITING ACTIVITY | authKW | 190446 | 1% | 100% | 3 |
10 | DERMATOL B | address | 142833 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 5831 | 27% | 0% | 128 |
2 | Oncology | 4847 | 52% | 0% | 249 |
3 | Medicine, Research & Experimental | 647 | 15% | 0% | 70 |
4 | Medical Laboratory Technology | 509 | 6% | 0% | 27 |
5 | Cell Biology | 63 | 8% | 0% | 38 |
6 | Pathology | 56 | 4% | 0% | 18 |
7 | Biotechnology & Applied Microbiology | 36 | 5% | 0% | 25 |
8 | Rheumatology | 19 | 1% | 0% | 7 |
9 | Surgery | 5 | 4% | 0% | 20 |
10 | Biochemistry & Molecular Biology | 3 | 7% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DERMATOL B | 142833 | 1% | 75% | 3 |
2 | CELL BIOL IMMUNOL EXPT ONCOL | 126964 | 0% | 100% | 2 |
3 | SERV DERMATOL B | 126964 | 0% | 100% | 2 |
4 | N MEM HLTH CARE | 84641 | 0% | 67% | 2 |
5 | ORTHOPAED CELL BIOL PHYSIOL | 84641 | 0% | 67% | 2 |
6 | ADV DIAGNOST DISCOVERY | 63482 | 0% | 100% | 1 |
7 | BIOCHEM INVEST AUGUST PI SUNYER | 63482 | 0% | 100% | 1 |
8 | BIOCHEM ONCOBIOL UNIT | 63482 | 0% | 100% | 1 |
9 | BYK | 63482 | 0% | 100% | 1 |
10 | CHIRURG PLAST 1 | 63482 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MELANOMA RESEARCH | 125873 | 12% | 3% | 59 |
2 | PIGMENT CELL RESEARCH | 1469 | 1% | 0% | 5 |
3 | ANTICANCER RESEARCH | 1304 | 4% | 0% | 20 |
4 | BRITISH JOURNAL OF DERMATOLOGY | 1275 | 3% | 0% | 15 |
5 | EUROPEAN JOURNAL OF CANCER | 1229 | 3% | 0% | 14 |
6 | JOURNAL OF CLINICAL ONCOLOGY | 1110 | 4% | 0% | 17 |
7 | BRITISH JOURNAL OF CANCER | 1001 | 4% | 0% | 17 |
8 | CYTOTECHNOLOGY | 734 | 1% | 0% | 5 |
9 | COLOMBIA MEDICA | 656 | 0% | 1% | 2 |
10 | UROLOGIC ONCOLOGY | 575 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIA | 914098 | 7% | 40% | 36 | Search MIA | Search MIA |
2 | CIRCULATING MELANOMA CELLS | 512083 | 2% | 73% | 11 | Search CIRCULATING+MELANOMA+CELLS | Search CIRCULATING+MELANOMA+CELLS |
3 | MELANOMA INHIBITORY ACTIVITY | 466444 | 3% | 57% | 13 | Search MELANOMA+INHIBITORY+ACTIVITY | Search MELANOMA+INHIBITORY+ACTIVITY |
4 | CD RAP | 451426 | 2% | 89% | 8 | Search CD+RAP | Search CD+RAP |
5 | TYROSINASE MRNA | 428499 | 2% | 75% | 9 | Search TYROSINASE+MRNA | Search TYROSINASE+MRNA |
6 | MELANOMA INHIBITING ACTIVITY | 317410 | 1% | 100% | 5 | Search MELANOMA+INHIBITING+ACTIVITY | Search MELANOMA+INHIBITING+ACTIVITY |
7 | SERUM S100 PROTEIN | 317410 | 1% | 100% | 5 | Search SERUM+S100+PROTEIN | Search SERUM+S100+PROTEIN |
8 | MELANOMA INHIBITORY ACTIVITY MIA | 253928 | 1% | 100% | 4 | Search MELANOMA+INHIBITORY+ACTIVITY+MIA | Search MELANOMA+INHIBITORY+ACTIVITY+MIA |
9 | MIA MELANOMA INHIBITING ACTIVITY | 190446 | 1% | 100% | 3 | Search MIA+MELANOMA+INHIBITING+ACTIVITY | Search MIA+MELANOMA+INHIBITING+ACTIVITY |
10 | CIRCULATION TUMOR CELLS | 126964 | 0% | 100% | 2 | Search CIRCULATION+TUMOR+CELLS | Search CIRCULATION+TUMOR+CELLS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOCELLIN, S , HOON, D , AMBROSI, A , NITTI, D , ROSSI, CR , (2006) THE PROGNOSTIC VALUE OF CIRCULATING TUMOR CELLS IN PATIENTS WITH MELANOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.CLINICAL CANCER RESEARCH. VOL. 12. ISSUE 15. P. 4605-4613 | 52 | 84% | 92 |
2 | BROCHEZ, L , NAEYAERT, JM , (2000) SEROLOGICAL MARKERS FOR MELANOMA.BRITISH JOURNAL OF DERMATOLOGY. VOL. 143. ISSUE 2. P. 256 -268 | 67 | 74% | 80 |
3 | GRADILONE, A , CIGNA, E , AGLIANO, AM , FRATI, L , (2010) TYROSINASE EXPRESSION AS A MOLECULAR MARKER FOR INVESTIGATING THE PRESENCE OF CIRCULATING TUMOR CELLS IN MELANOMA PATIENTS.CURRENT CANCER DRUG TARGETS. VOL. 10. ISSUE 5. P. 529 -538 | 58 | 71% | 2 |
4 | RODIC, S , MIHALCIOIU, C , SALEH, RR , (2014) DETECTION METHODS OF CIRCULATING TUMOR CELLS IN CUTANEOUS MELANOMA: A SYSTEMATIC REVIEW.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 91. ISSUE 1. P. 74 -92 | 62 | 44% | 7 |
5 | KRUIJFF, S , BASTIAANNET, E , KOBOLD, ACM , VAN GINKEL, RJ , SUURMEIJER, AJH , HOEKSTRA, HJ , (2009) S-100B CONCENTRATIONS PREDICT DISEASE-FREE SURVIVAL IN STAGE III MELANOMA PATIENTS.ANNALS OF SURGICAL ONCOLOGY. VOL. 16. ISSUE 12. P. 3455 -3462 | 37 | 79% | 15 |
6 | SZENAJCH, J , JASINSKI, B , SYNOWIEC, A , KULIK, J , CHOMICKA, M , STRUZYNA, J , NOWECKI, Z , RUTKOWSKI, P , RUKA, W , KUPSC, W , ET AL (2003) PROGNOSTIC VALUE OF MULTIPLE REVERSE TRANSCRIPTION-PCR TYROSINASE TESTING FOR CIRCULATING NEOPLASTIC CELLS IN MALIGNANT MELANOMA.CLINICAL CHEMISTRY. VOL. 49. ISSUE 9. P. 1450-1457 | 37 | 93% | 27 |
7 | PALMER, SR , ERICKSON, LA , ICHETOVKIN, I , KNAUER, DJ , MARKOVIC, SN , (2011) CIRCULATING SEROLOGIC AND MOLECULAR BIOMARKERS IN MALIGNANT MELANOMA.MAYO CLINIC PROCEEDINGS. VOL. 86. ISSUE 10. P. 981 -990 | 55 | 47% | 27 |
8 | QUAGLINO, P , SAVOIA, P , OSELLA-ABATE, S , BERNENGO, MG , (2004) RT-PCR TYROSINASE EXPRESSION IN THE PERIPHERAL BLOOD OF MELANOMA PATIENTS.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 4. ISSUE 5. P. 727-741 | 52 | 60% | 12 |
9 | MEDIC, S , PEARCE, RL , HEENAN, PJ , ZIMAN, M , (2007) MOLECULAR MARKERS OF CIRCULATING MELANOMA CELLS.PIGMENT CELL RESEARCH. VOL. 20. ISSUE 2. P. 80-91 | 51 | 51% | 34 |
10 | BOSSERHOFF, AK , BUETTNER, R , (2002) EXPRESSION, FUNCTION AND CLINICAL RELEVANCE OF MIA (MELANOMA INHIBITORY ACTIVITY).HISTOLOGY AND HISTOPATHOLOGY. VOL. 17. ISSUE 1. P. 289-300 | 31 | 94% | 35 |
Classes with closest relation at Level 1 |